{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:42:18Z","timestamp":1791837738446,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]},{"name":"DST ,New Delhi, Women scientist scheme","award":["SR\/WOS-A\/LS-642\/2012(G)."],"award-info":[{"award-number":["SR\/WOS-A\/LS-642\/2012(G)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) presents clinical symptoms of menstrual abnormalities, excessive hair growth (hirsutism), scalp hair loss, acne and infertility. Metabolic abnormalities such as obesity, insulin resistance, glucose intolerance and cardiovascular problems constitute an essential part of PCOS, all of which can have significant long-term health consequences. Low-grade chronic inflammation demonstrated by persistent moderately elevated serum levels\u00a0of inflammatory and coagulatory markers plays a critical role in the pathogenesis of PCOS. Oral contraceptive pills (OCPs) constitute the mainstay of pharmacologic therapy for women with PCOS to regularize cyclicity and ameliorate androgen excess. On the other hand, OCP use is associated with various venous thromboembolic and proinflammatory events in the general population. PCOS women always carriers the increased lifetime risk of these events. The studies on the effect of OCPs on inflammatory, coagulation and metabolic parameters in PCOS are less robust. Therefore in this study, we investigated and compared the messenger RNA (mRNA) expression profiles of genes implicated in inflammatory and coagulation\u00a0pathways between drug-naive and OCP-treated PCOS women. The selected genes include intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1). Furthermore, the correlation between the selected markers and various metabolic indices in the OCP group has also been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The relative amounts of ICAM-1, TNF-\u03b1, MCP-1 and PAI-1 mRNA in peripheral blood mononuclear cells from 25 drug-naive PCOS subjects (controls) and 25 PCOS subjects who received OCPs containing 0.03\u00a0mg-ethinyl-estradiol and 0.15\u00a0mg-levonorgestrel for at least six\u00a0months (cases)\u00a0were estimated using real-time qPCR. The statistical interpretation was conducted using SPSS version 20.0 (SPSS, Inc, Chicago, IL), Epi Info version 2002 (Disease Control and Prevention Centres, Atlanta, GA) and GraphPad Prism 5 (GraphPad Software, La Jolla, CA) software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Six months of OCP therapy enhanced the expression of inflammatory genes viz ICAM-1, TNF-\u03b1 and MCP-1 mRNA in PCOS women by 2.54, 2.05 and 1.74 folds, respectively, in this study. However, PAI-1 mRNA in the OCP group showed no significant increase. Furthermore, in cases, ICAM-1 mRNA expression positively correlated with body mass index (BMI) (p\u2009=\u20090.01), fasting insulin (p\u2009=\u20090.01), insulin 2 h p\u2009=\u20090.02), glucose 2 h (p\u2009=\u20090.01) and triglycerides (p\u2009=\u20090.01). TNF-\u03b1 mRNA expression positively correlated with fasting insulin (p\u2009=\u20090.0007). MCP-1 mRNA expression positively correlated with (BMI) (p\u2009=\u20090.002).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OCPs helped reduce clinical hyperandrogenism and regularise menstrual cycles in women with PCOS. However, OCP use was associated with increased fold expression of inflammatory markers\u00a0which positively correlated with metabolic abnormalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02187-5","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:04:57Z","timestamp":1676459097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women"],"prefix":"10.1186","volume":"23","author":[{"given":"Syed Douhath","family":"Yousuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ashraf","family":"Ganie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uneeb","family":"Urwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mudasir","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Afzal","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashooq Ahmad","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir","family":"Manzoor-ul-Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Mudassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"4","key":"2187_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261\u201371.","journal-title":"J Hum Reprod Sci"},{"issue":"2","key":"2187_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijgo.13125","volume":"149","author":"MA Ganie","year":"2020","unstructured":"Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J. Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: a cross-sectional study. Int J Gynaecol Obstet. 2020;149(2):231\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"2187_CR3","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.dsx.2019.05.003","volume":"13","author":"SUA Rasool","year":"2019","unstructured":"Rasool SUA, Ashraf S, Nabi M, Rashid F, Fazili KM, Amin S. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome. Diabetes Metab Syndr. 2019;13(3):2098\u2013105.","journal-title":"Diabetes Metab Syndr"},{"key":"2187_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fendo.2019.00879","volume":"10","author":"F Cirillo","year":"2019","unstructured":"Cirillo F, Catellani C, Lazzeroni P, Sartori C, Nicoli A, Amarri S, et al. MiRNAs regulating insulin sensitivity are dysregulated in polycystic ovary syndrome (PCOS) ovaries and are associated with markers of inflammation and insulin sensitivity. Front Endocrinol (Lausanne). 2019;10:879.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2187_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejogrb.2019.06.018","volume":"240","author":"Q Sun","year":"2019","unstructured":"Sun Q, Yang Y, Peng X, Zhang Y, Gao Y, Wang F, et al. Coagulation parameters predictive of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2019;240:36\u201340.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2187_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13048-019-0566-5","volume":"12","author":"NM Rashad","year":"2019","unstructured":"Rashad NM, El-Shal AS, Abomandour HG, Aboelfath AMK, Rafeek MES, Badr MS, et al. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome. J Ovarian Res. 2019;12(1):97.","journal-title":"J Ovarian Res"},{"issue":"4","key":"2187_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/13813455.2016.1190760","volume":"122","author":"DI Koleva","year":"2016","unstructured":"Koleva DI, Orbetzova MM, Nikolova JG, Tyutyundzhiev SB. Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome. Arch Physiol Biochem. 2016;122(4):223\u20137.","journal-title":"Arch Physiol Biochem"},{"issue":"11","key":"2187_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1055\/a-0992-9114","volume":"128","author":"E Hatziagelaki","year":"2020","unstructured":"Hatziagelaki E, Pergialiotis V, Kannenberg JM, Trakakis E, Tsiavou A, Markgraf DF, et al. Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2020;128(11):723\u201330.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"2187_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF02786454","volume":"17","author":"JS Hayflick","year":"1998","unstructured":"Hayflick JS, Kilgannon P, Gallatin WM. The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol Res. 1998;17(3):313\u201327.","journal-title":"Immunol Res"},{"issue":"7","key":"2187_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/0092-8674(93)90367-Y","volume":"73","author":"LR Languino","year":"1993","unstructured":"Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell. 1993;73(7):1423\u201334.","journal-title":"Cell"},{"issue":"4","key":"2187_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1389450120666190927122553","volume":"21","author":"L Kong","year":"2020","unstructured":"Kong L, Yang X. Study of intercellular adhesion molecule-1 (ICAM-1) in bone homeostasis. Curr Drug Targets. 2020;21(4):328\u201337.","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2187_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCRESAHA.117.306666","volume":"117","author":"DS Milstone","year":"2015","unstructured":"Milstone DS, Ilyama M, Chen M, O\u2019Donnell P, Davis VM, Plutzky J, et al. Differential role of an NF-\u03baB transcriptional response element in endothelial versus intimal cell VCAM-1 expression. Circ Res. 2015;117(2):166\u201377.","journal-title":"Circ Res"},{"issue":"6","key":"2187_CR13","first-page":"1177","volume":"101","author":"G Amato","year":"2003","unstructured":"Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003;101(6):1177\u201382.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2187_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164021","volume":"11","author":"L Gao","year":"2016","unstructured":"Gao L, Gu Y, Yin X. High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PLoS ONE. 2016;11(10): e0164021.","journal-title":"PLoS ONE"},{"issue":"1","key":"2187_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","volume":"25","author":"V Bianconi","year":"2018","unstructured":"Bianconi V, Sahebkar A, Atkin SL, Pirro M. The regulation and importance of monocyte chemoattractant protein-1. Curr Opin Hematol. 2018;25(1):44\u201351.","journal-title":"Curr Opin Hematol"},{"issue":"16","key":"2187_CR16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2174\/1389450120666190715102510","volume":"20","author":"T Urano","year":"2019","unstructured":"Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Recognition of plasminogen activator inhibitor type 1 as the primary regulator of fibrinolysis. Curr Drug Targets. 2019;20(16):1695\u2013701.","journal-title":"Curr Drug Targets"},{"key":"2187_CR17","doi-asserted-by":"publisher","first-page":"17714","DOI":"10.1038\/srep17714","volume":"6","author":"J Yarmolinsky","year":"2016","unstructured":"Yarmolinsky J, Bordin Barbieri N, Weinmann T, Ziegelmann PK, Duncan BB, In\u00eas SM. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep. 2016;6:17714.","journal-title":"Sci Rep"},{"key":"2187_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2019.11.019","volume":"185","author":"K Gariani","year":"2020","unstructured":"Gariani K, Hugon-Rodin J, Philippe J, Righini M, Blondon M. Association between polycystic ovary syndrome and venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2020;185:102\u20138.","journal-title":"Thromb Res"},{"issue":"4","key":"2187_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","volume":"34","author":"P Jin","year":"2018","unstructured":"Jin P, Xie Y. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(4):272\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2187_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/1076029617727857","volume":"24","author":"P Dulicek","year":"2018","unstructured":"Dulicek P, Ivanova E, Kostal M, Sadilek P, Beranek M, Zak P, et al. Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use. Clin Appl Thromb Hemost. 2018;24(5):797\u2013802.","journal-title":"Clin Appl Thromb Hemost"},{"key":"2187_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","volume":"73","author":"M Amiri","year":"2017","unstructured":"Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism. 2017;73:22\u201335.","journal-title":"Metabolism"},{"issue":"1","key":"2187_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpag.2016.06.010","volume":"30","author":"SD Yousuf","year":"2017","unstructured":"Yousuf SD, Rashid F, Mattoo T, Shekhar C, Mudassar S, Zargar MA, et al. Does the oral contraceptive pill increase plasma intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and tumor necrosis factor-\u03b1 levels in women with polycystic ovary syndrome: a pilot study. J Pediatr Adolesc Gynecol. 2017;30(1):58\u201362.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"Suppl","key":"2187_CR23","first-page":"S151","volume":"148","author":"SD Yousuf","year":"2018","unstructured":"Yousuf SD, Ganie MA, Jeelani S, Mudassar S, Shah ZA, Zargar MA, et al. Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: an observational pilot study. Indian J Med Res. 2018;148(Suppl):S151\u20135.","journal-title":"Indian J Med Res"},{"issue":"1","key":"2187_CR24","doi-asserted-by":"publisher","first-page":"10182","DOI":"10.1038\/s41598-019-46644-4","volume":"9","author":"S Manzoor","year":"2019","unstructured":"Manzoor S, Ganie MA, Amin S, Shah ZA, Bhat IA, Yousuf SD, et al. Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: an observational study. Sci Rep. 2019;9(1):10182.","journal-title":"Sci Rep"},{"issue":"3","key":"2187_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12291-020-00901-w","volume":"36","author":"S Manzoor","year":"2021","unstructured":"Manzoor S, Ganie MA, Majid S, Shabir I, Kawa IA, Fatima Q, et al. Analysis of intrinsic and extrinsic coagulation pathway factors in OCP treated PCOS women. Indian J Clin Biochem. 2021;36(3):278\u201387.","journal-title":"Indian J Clin Biochem"},{"key":"2187_CR26","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2187_CR27","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2187_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.snb.2018.03.053","volume":"265","author":"B Xing","year":"2018","unstructured":"Xing B, Zhu W, Zheng X, Zhu Y, Wei Q, Wu D. Electrochemiluminescence immunosensor based on quenching effect of SiO2@ PDA on SnO2\/rGO\/Au NPs-luminol for insulin detection. Sens Actuators B Chem. 2018;265:403\u201311.","journal-title":"Sens Actuators B Chem"},{"issue":"7","key":"2187_CR29","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2187_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"key":"2187_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2144\/05391RV01","volume":"39","author":"ML Wong","year":"2005","unstructured":"Wong ML, Medrano JF. One-step versus two-step real-time PCR. Biotechniques. 2005;39:75\u201385.","journal-title":"Biotechniques"},{"issue":"6","key":"2187_CR32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"key":"2187_CR33","unstructured":"Pfaffl MW, Bustin S. AZ of quantitative PCR. Quantification strategies in real-time PCR. 2004;1:87\u2013112"},{"key":"2187_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mimet.2018.02.011","volume":"147","author":"E Villa-Rodr\u00edguez","year":"2018","unstructured":"Villa-Rodr\u00edguez E, Ibarra-G\u00e1mez C, de Los S-V. Extraction of high-quality RNA from Bacillus subtilis with a lysozyme pre-treatment followed by the Trizol method. J Microbiol Methods. 2018;147:14\u20136.","journal-title":"J Microbiol Methods"},{"issue":"11","key":"2187_CR35","first-page":"813","volume":"4","author":"DB Petitti","year":"2006","unstructured":"Petitti DB. Oral contraceptives and hypercoagulation. Clin Adv Hematol Oncol. 2006;4(11):813\u20135.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"2187_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejogrb.2011.03.015","volume":"157","author":"W Hu","year":"2011","unstructured":"Hu W, Qiao J, Yang Y, Wang L, Li R. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):53\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2187_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.fertnstert.2010.08.030","volume":"95","author":"CS Atabekoglu","year":"2011","unstructured":"Atabekoglu CS, S\u00f6nmezer M, \u00d6zmen B, Yarc\u0131 A, Akb\u0131y\u0131k F, Ta\u015f\u00e7\u0131 T, et al. Increased monocyte chemoattractant protein-1 levels indicating early vascular damage in lean young PCOS patients. Fertil Steril. 2011;95(1):295\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"2187_CR38","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.dsx.2019.04.032","volume":"13","author":"Q Fatima","year":"2019","unstructured":"Fatima Q, Amin S, Kawa IA, Jeelani H, Manzoor S, Rizvi SM, et al. Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): a case-control study. Diabetes Metab Syndr. 2019;13(3):1957\u201361.","journal-title":"Diabetes Metab Syndr"},{"key":"2187_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fendo.2019.00699","volume":"10","author":"MA Ganie","year":"2019","unstructured":"Ganie MA, Sahar T, Rashid A, Wani IA, Nisar S, Sathyapalan T, et al. Comparative evaluation of biomarkers of inflammation among Indian women with polycystic ovary syndrome (PCOS) consuming vegetarian vs. non-vegetarian diet. Front Endocrinol. 2019;10:699.","journal-title":"Front Endocrinol"},{"key":"2187_CR40","first-page":"205","volume-title":"Managing the PCOS-related symptoms of hirsutism, acne, and female pattern hair loss. Polycystic ovary syndrome","author":"T Shah","year":"2022","unstructured":"Shah T, Lieman HJ. Managing the PCOS-related symptoms of hirsutism, acne, and female pattern hair loss. Polycystic ovary syndrome. Berlin: Springer; 2022. p. 205\u201331."},{"issue":"14","key":"2187_CR41","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1056\/NEJMcp033487","volume":"352","author":"WD James","year":"2005","unstructured":"James WD. Clinical practice. Acne N Engl J Med. 2005;352(14):1463\u201372.","journal-title":"Acne N Engl J Med"},{"key":"2187_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","volume":"499","author":"J-l Zhu","year":"2019","unstructured":"Zhu J-l, Chen Z, Feng W-J, Long S-l, Mo Z-C. Sex hormone-binding globulin and polycystic ovary syndrome. Clin Chim Acta. 2019;499:142\u20138.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2187_CR43","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","volume":"17","author":"K Elter","year":"2002","unstructured":"Elter K, Imir G, Durmusoglu F. Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study. Hum Reprod. 2002;17(7):1729\u201337.","journal-title":"Hum Reprod"},{"issue":"2","key":"2187_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/humrep\/del407","volume":"22","author":"S Nader","year":"2007","unstructured":"Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod. 2007;22(2):317\u201322.","journal-title":"Hum Reprod"},{"issue":"1","key":"2187_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/qjmed\/94.1.31","volume":"94","author":"VL Armstrong","year":"2001","unstructured":"Armstrong VL, Wiggam MI, Ennis CN, Sheridan B, Traub AI, Atkinson AB, et al. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol\/cyproterone acetate. QJM. 2001;94(1):31\u20137.","journal-title":"QJM"},{"issue":"4","key":"2187_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","volume":"15","author":"D Cibula","year":"2000","unstructured":"Cibula D, C\u00edfkov\u00e1 R, Fanta M, Poledne R, Zivny J, Skibov\u00e1 J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod. 2000;15(4):785\u20139.","journal-title":"Hum Reprod"},{"issue":"4","key":"2187_CR47","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1152\/physrev.2001.81.4.1535","volume":"81","author":"S Nilsson","year":"2001","unstructured":"Nilsson S, M\u00e4kel\u00e4 S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev. 2001;81(4):1535\u201365.","journal-title":"Physiol Rev"},{"issue":"Pt 4","key":"2187_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1242\/jcs.00247","volume":"116","author":"M Robinson-Rechavi","year":"2003","unstructured":"Robinson-Rechavi M, Escriva Garcia H, Laudet V. The nuclear receptor superfamily. J Cell Sci. 2003;116(Pt 4):585\u20136.","journal-title":"J Cell Sci"},{"issue":"2","key":"2187_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1507\/endocrj.53.157","volume":"53","author":"M Kishimoto","year":"2006","unstructured":"Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, et al. Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J. 2006;53(2):157\u201372.","journal-title":"Endocr J"},{"issue":"4","key":"2187_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0378-5122(02)00157-3","volume":"42","author":"H Tatsumi","year":"2002","unstructured":"Tatsumi H, Kitawaki J, Tanaka K, Hosoda T, Honjo H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas. 2002;42(4):287\u201394.","journal-title":"Maturitas"},{"issue":"1","key":"2187_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","volume":"4","author":"M van Rooijen","year":"2006","unstructured":"van Rooijen M, Hansson LO, Frosteg\u00e5rd J, Silveira A, Hamsten A, Bremme K. Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response. J Thromb Haemost. 2006;4(1):77\u201382.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2187_CR52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/01.GME.0000153888.94399.AF","volume":"12","author":"M Hemelaar","year":"2005","unstructured":"Hemelaar M, van der Mooren MJ, van Baal WM, Schalkwijk CG, Kenemans P, Stehouwer CD. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women. Menopause. 2005;12(5):526\u201335.","journal-title":"Menopause"},{"issue":"14","key":"2187_CR53","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2169\/internalmedicine.48.2177","volume":"48","author":"O Bilgir","year":"2009","unstructured":"Bilgir O, Kebapcilar L, Taner C, Bilgir F, Kebapcilar A, Bozkaya G, et al. The effect of ethinylestradiol (EE)\/cyproterone acetate (CA) and EE\/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS). Intern Med. 2009;48(14):1193\u20139.","journal-title":"Intern Med"},{"issue":"3","key":"2187_CR54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/humrep\/dep459","volume":"25","author":"MJ Chen","year":"2010","unstructured":"Chen MJ, Yang WS, Chen HF, Kuo JJ, Ho HN, Yang YS, et al. Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome. Hum Reprod. 2010;25(3):779\u201385.","journal-title":"Hum Reprod"},{"issue":"3","key":"2187_CR55","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/EJE-08-0725","volume":"160","author":"M Luque-Ram\u00edrez","year":"2009","unstructured":"Luque-Ram\u00edrez M, Mendieta-Azcona C, del Rey S\u00e1nchez JM, Mat\u00edes M, Escobar-Morreale HF. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking. Eur J Endocrinol. 2009;160(3):469\u201380.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2187_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000334175","volume":"73","author":"KM Seow","year":"2012","unstructured":"Seow KM, Juan CC, Wang PH, Ho LT, Hwang JL. Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome. Gynecol Obstet Invest. 2012;73(3):236\u201341.","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"2187_CR57","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/humrep\/der096","volume":"26","author":"A Lindholm","year":"2011","unstructured":"Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundstr\u00f6m Poromaa I, et al. No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod. 2011;26(6):1478\u201385.","journal-title":"Hum Reprod"},{"issue":"6","key":"2187_CR58","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/db08-0127","volume":"57","author":"BK Tan","year":"2008","unstructured":"Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes. 2008;57(6):1501\u20137.","journal-title":"Diabetes"},{"issue":"2","key":"2187_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/JOE-13-0277","volume":"219","author":"BK Tan","year":"2013","unstructured":"Tan BK, Chen J, Adya R, Ramanjaneya M, Patel V, Randeva HS. Metformin increases the novel adipokine adipolin\/CTRP12: role of the AMPK pathway. J Endocrinol. 2013;219(2):101\u20138.","journal-title":"J Endocrinol"},{"key":"2187_CR60","doi-asserted-by":"publisher","first-page":"9591509","DOI":"10.1155\/2018\/9591509","volume":"2018","author":"SF de Medeiros","year":"2018","unstructured":"de Medeiros SF, de Medeiros MAS, Santos NS, Barbosa BB, Yamamoto MMW. Combined oral contraceptive effects on low-grade chronic inflammatory mediators in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Inflamm. 2018;2018:9591509.","journal-title":"Int J Inflamm"},{"issue":"1","key":"2187_CR61","first-page":"54","volume":"38","author":"M K\u00fc\u00e7\u00fck","year":"2011","unstructured":"K\u00fc\u00e7\u00fck M, Sezer SD, Odaba\u015fi AR, G\u00fcner Z, Yuksel H, Serter M. The effect of low-dose combined oral contraceptive containing 100 ug levonorgestrel on plasma plasminogen activator inhibitor-1 concentrations. Clin Exp Obstet Gynecol. 2011;38(1):54\u20136.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"2187_CR62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","volume":"93","author":"HJ Teede","year":"2010","unstructured":"Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy. Fertil Steril. 2010;93(1):184\u201391.","journal-title":"Fertil Steril"},{"issue":"6","key":"2187_CR63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrendo.2009.62","volume":"5","author":"B F\u00e8ve","year":"2009","unstructured":"F\u00e8ve B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305\u201311.","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 3","key":"2187_CR64","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","volume":"27","author":"GS Hotamisligil","year":"2003","unstructured":"Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S53\u20135.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"2187_CR65","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","volume":"11","author":"DE Moller","year":"2000","unstructured":"Moller DE. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab. 2000;11(6):212\u20137.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"2187_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1084\/jem.193.2.263","volume":"193","author":"Y Kawazoe","year":"2001","unstructured":"Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, et al. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)\/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med. 2001;193(2):263\u20139.","journal-title":"J Exp Med"},{"issue":"1","key":"2187_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","volume":"60","author":"J Panee","year":"2012","unstructured":"Panee J. Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine. 2012;60(1):1\u201312.","journal-title":"Cytokine"},{"issue":"1","key":"2187_CR68","first-page":"116","volume":"46","author":"N Koca","year":"2021","unstructured":"Koca N, Ayar K, Bal \u00d6, Ersoy C. The evaluation of the role of BMI and insulin resistance on inflammatory markers, PAI-1 levels and arterial stiffness in newly diagnosed type 2 diabetes mellitus patients. Miner Endocrinol. 2021;46(1):116\u201323.","journal-title":"Miner Endocrinol"},{"issue":"1","key":"2187_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-84586-y","volume":"11","author":"ASM Moin","year":"2021","unstructured":"Moin ASM, Sathyapalan T, Diboun I, Elrayess MA, Butler AE, Atkin SL. Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome. Sci Rep. 2021;11(1):1\u20137.","journal-title":"Sci Rep"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02187-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:05:14Z","timestamp":1676459114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2187"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02187-5","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional ethics committee approved the study, Sher-i-Kashmir Institute of Medical Sciences, Soura, under IEC No: SIMS 131\/IEC-SKIMS\/2013-6479: dated 09-07-2013.Women diagnosed with PCOS who volunteered to participate were required to complete an informed consent form to be enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All methods used in the current study were carried out following relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical guidelines"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}